2025-2026 Regular Session • New York Legislature
A07920
Legislative Summary
Provides for patient access to FDA approved abuse-deterrent technology to help combat opioid abuse.
Demographic Impact
Overall analysis of equity impact
70% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
4/11/2025
referred to insurance
Assembly
Status Information
Current Status
Introduced(4/11/2025)
Chamber
Assembly
Committee
Insurance(Assembly)
Sponsors
Republican: 4
Primary Sponsor
Matthew Slater
Republican